INS and sarcopenia: Fourth, although one aim of our study was to investigate the effects of metformin on sarcopenia, other hypoglycemic drugs in our study included sulfonylureas/glinides, alpha-glucosidase inhibitors, and insulin, and these were not specifically subcategorized, even though they might also have elicited protective effects against sarcopenia.